These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 28127201

  • 21. Pancreatic neuroendocrine neoplasms: Correlation between MR features and pathological tumor grades.
    Jin F, Wang K, Qin TT, Li X, Guo F, Ma GN, Hu XH, Han P.
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):587-595. PubMed ID: 28786064
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Role of diffusion-weighted MR imaging in predicting the grade of nonfunctional pancreatic neuroendocrine tumors.
    Kulali F, Semiz-Oysu A, Demir M, Segmen-Yilmaz M, Bukte Y.
    Diagn Interv Imaging; 2018 May; 99(5):301-309. PubMed ID: 29258825
    [Abstract] [Full Text] [Related]

  • 26. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
    Park HJ, Kim HJ, Kim KW, Kim SY, Choi SH, You MW, Hwang HS, Hong SM.
    Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
    [Abstract] [Full Text] [Related]

  • 27. Diagnostic Performance of Apparent Diffusion Coefficient for Prediction of Grading of Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-analysis.
    Zong RL, Geng L, Wang X, Xie D.
    Pancreas; 2019 Feb; 48(2):151-160. PubMed ID: 30640226
    [Abstract] [Full Text] [Related]

  • 28. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.
    Canellas R, Burk KS, Parakh A, Sahani DV.
    AJR Am J Roentgenol; 2018 Feb; 210(2):341-346. PubMed ID: 29140113
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.
    Belousova E, Karmazanovsky G, Kriger A, Kalinin D, Mannelli L, Glotov A, Karelskaya N, Paklina O, Kaldarov A.
    Clin Radiol; 2017 Feb; 72(2):150-158. PubMed ID: 27890421
    [Abstract] [Full Text] [Related]

  • 31. Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions.
    Kang KM, Lee JM, Yoon JH, Kiefer B, Han JK, Choi BI.
    Radiology; 2014 Feb; 270(2):444-53. PubMed ID: 24126370
    [Abstract] [Full Text] [Related]

  • 32. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R, Suzuki K, Ogawa H, Komada T, Naganawa S.
    Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms.
    D'Onofrio M, Ciaravino V, Cardobi N, De Robertis R, Cingarlini S, Landoni L, Capelli P, Bassi C, Scarpa A.
    Sci Rep; 2019 Feb 18; 9(1):2176. PubMed ID: 30778137
    [Abstract] [Full Text] [Related]

  • 35. Pancreatic neuroendocrine tumors: correlation between histogram analysis of apparent diffusion coefficient maps and tumor grade.
    Pereira JA, Rosado E, Bali M, Metens T, Chao SL.
    Abdom Imaging; 2015 Oct 18; 40(8):3122-8. PubMed ID: 26280127
    [Abstract] [Full Text] [Related]

  • 36. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
    Wang H, Cheng L, Zhang X, Wang D, Guo A, Gao Y, Ye H.
    Radiology; 2010 Oct 18; 257(1):135-43. PubMed ID: 20713607
    [Abstract] [Full Text] [Related]

  • 37. Gliomas: diffusion kurtosis MR imaging in grading.
    Van Cauter S, Veraart J, Sijbers J, Peeters RR, Himmelreich U, De Keyzer F, Van Gool SW, Van Calenbergh F, De Vleeschouwer S, Van Hecke W, Sunaert S.
    Radiology; 2012 May 18; 263(2):492-501. PubMed ID: 22403168
    [Abstract] [Full Text] [Related]

  • 38. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
    Ohno Y, Koyama H, Onishi Y, Takenaka D, Nogami M, Yoshikawa T, Matsumoto S, Kotani Y, Sugimura K.
    Radiology; 2008 Aug 18; 248(2):643-54. PubMed ID: 18539889
    [Abstract] [Full Text] [Related]

  • 39. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
    Rosenkrantz AB, Niver BE, Fitzgerald EF, Babb JS, Chandarana H, Melamed J.
    AJR Am J Roentgenol; 2010 Nov 18; 195(5):W344-51. PubMed ID: 20966299
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.